Published Date: 09 Mar 2023
Recent studies have shown poor outcomes in infants and children with postnatal development.
Read Full NewsHere's some of what is coming soon to NeurologyLive® this week.
Allison B. Reiss, MD, associate professor of medicine at NYU Grossman Long Island School of Medicine discussed the often-overlooked early signs of early-onset Alzheimer disease.
Gefurulimab (Klygefa), a once-weekly, self-administered complement C5 inhibitor from Alexion and AstraZeneca, is now approved in the US for adults with AChR-antibody-positive generalized myasthenia gravis.
A new FDA filing seeks to expand cenobamate's epilepsy indication to primary generalized tonic-clonic seizures, based on positive phase 3 trial data.
The professor of neurology at UT Southwestern Medical Center discussed emerging trials, proposed changes to myelitis diagnostic criteria and nomenclature, and the unmet needs raised by patients at this year’s symposium.
A new global phase 2 trial, TARBELA-AD, will test RG6434, Roche's investigational oral NLRP3 inflammasome inhibitor, in adults with early symptomatic Alzheimer disease.
A pivotal phase 2/3 trial of Zhimeng Biopharma's CB03-154, an oral KCNQ2/3 potassium channel opener, has completed enrollment in amyotrophic lateral sclerosis.
1.
Kidney cancer: Understanding what a renal cell carcinoma diagnosis means
2.
Study opens up possibility of bespoke prostate cancer treatment
3.
Mosunetuzumab in Follicular Lymphoma: Durable Responses and Manageable Safety
4.
Imetelstat for MDS-relateret anemia er godkendt af Food and Drug Administrations panel.
5.
Lung Cancer Screening Rates in Eligible Adults Remain Low, Uneven
1.
A Comprehensive Guide to Living with Cutaneous T Cell Lymphoma: Tips & Strategies
2.
Exploring the Impact of Adrenal Myelolipoma on the Human Body
3.
Practical Standards in Hematology for Healthcare Excellence
4.
Living with Shwachman-Diamond Syndrome: A Journey of Hope and Strength
5.
Cancer Treatment Tolerance in Very Old Adults
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Clinical Excellence in Hematology
2.
From Relapse to Remission : Chasing the Invisible and Redefining Long-Term Survival in Adult R/R B-Cell ALL
3.
Efficient Management of First line ALK-rearranged NSCLC - Part III
4.
The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion
5.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation